Kathleen Selleng1, Marcel Baschin1, Berthold Henkel2, Gregor Jenichen2, Karl-Christian Thies3,4, Marcus Rudolph3,5, Florian Reifferscheid3,6, Jörg Braun3, Malte Hannich7, Theresa Winter7, Klaus Hahnenkamp2, Andreas Greinacher1. 1. Institut für Immunologie und Transfusionsmedizin, Abteilung Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany. 2. Klinik für Anästhesiologie, Universitätsmedizin Greifswald, Greifswald, Germany. 3. DRF Stiftung Luftrettung gemeinnützige AG, Wissenschaftlicher Arbeitskreis, Filderstadt, Germany. 4. Universitätsklinik für Anästhesiologie, Intensiv-, Notfallmedizin, Transfusionsmedizin und Schmerztherapie, EvKB, Universitätsklinikum OWL der Universität Bielefeld, Campus Bielefeld-Bethel, Bielefeld, Germany. 5. Universitätsmedizin Mannheim, Klinik für Anästhesiologie und operative Intensivmedizin, Mannheim, Germany. 6. Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Anästhesiologie und Operative Intensivmedizin, Kiel, Germany. 7. Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
Abstract
BACKGROUND: Long patient transport times to trauma centers are a well-known problem in sparsely populated regions with a low hospital density. Transfusion of red blood cell concentrates (RBC) and plasma improves outcome of trauma patients with severe bleeding. Helicopter emergency services (HEMS) are frequently employed to provide early advanced medical care and to reduce time to hospital admission. Supplying HEMS with blood products allows prehospital transfusion and may help to prevent exsanguination or prolonged hemorrhagic shock. We have investigated the maintenance of blood product quality under air transport conditions and the logistical steps to introduce a HEMS blood depot into routine practice. METHODS: A risk analysis was performed and a validation plan developed. A special, commercially available transport container for blood products was identified. Maintenance of temperature conditions between 2 and 6°C in the box were monitored at ambient temperatures up to 35°C over 48 h. Quality of blood products before and after helicopter air transport were evaluated including (1) for RBCs: hemoglobin, hematocrit, hemolysis rate; (2) for thawed plasma: aPTT, INR, single clotting factor activities. The logistics for blood supply of the regional HEMS were developed by the transfusion service of the Greifswald University Hospital in collaboration with the in-hospital transport team, the HEMS team, and the HEMS operator. RESULTS: The transport container maintained a temperature below 6°C up to 36 h at 35°C ambient temperature. Vibration during helicopter operation did not impair quality of RBC and thawed plasma. To provide blood products for HEMS at least two transport containers and an additional set of cooling tiles is needed as the cooling tiles need a special temperature priming over 20 h. The two boxes were used at alternate days. To reduce wastage, RBCs and thawed plasmas were exchanged every fourth day and reintegrated into the blood bank inventory for further in-hospital use. CONCLUSIONS: Supplying HEMS with RBCs and plasma is feasible. Helicopter transport has no negative impact on blood product quality. The logistic challenges require close collaboration between the HEMS team and the blood transfusion service.
BACKGROUND: Long patient transport times to trauma centers are a well-known problem in sparsely populated regions with a low hospital density. Transfusion of red blood cell concentrates (RBC) and plasma improves outcome of trauma patients with severe bleeding. Helicopter emergency services (HEMS) are frequently employed to provide early advanced medical care and to reduce time to hospital admission. Supplying HEMS with blood products allows prehospital transfusion and may help to prevent exsanguination or prolonged hemorrhagic shock. We have investigated the maintenance of blood product quality under air transport conditions and the logistical steps to introduce a HEMS blood depot into routine practice. METHODS: A risk analysis was performed and a validation plan developed. A special, commercially available transport container for blood products was identified. Maintenance of temperature conditions between 2 and 6°C in the box were monitored at ambient temperatures up to 35°C over 48 h. Quality of blood products before and after helicopter air transport were evaluated including (1) for RBCs: hemoglobin, hematocrit, hemolysis rate; (2) for thawed plasma: aPTT, INR, single clotting factor activities. The logistics for blood supply of the regional HEMS were developed by the transfusion service of the Greifswald University Hospital in collaboration with the in-hospital transport team, the HEMS team, and the HEMS operator. RESULTS: The transport container maintained a temperature below 6°C up to 36 h at 35°C ambient temperature. Vibration during helicopter operation did not impair quality of RBC and thawed plasma. To provide blood products for HEMS at least two transport containers and an additional set of cooling tiles is needed as the cooling tiles need a special temperature priming over 20 h. The two boxes were used at alternate days. To reduce wastage, RBCs and thawed plasmas were exchanged every fourth day and reintegrated into the blood bank inventory for further in-hospital use. CONCLUSIONS: Supplying HEMS with RBCs and plasma is feasible. Helicopter transport has no negative impact on blood product quality. The logistic challenges require close collaboration between the HEMS team and the blood transfusion service.
Authors: Thomas Thiele; Sarah Kellner; Gregor Hron; Christina Wasner; Matthias Nauck; Kathrin Zimmermann; Antje Wessel; Theodore E Warkentin; Andreas Greinacher; Kathleen Selleng Journal: Transfusion Date: 2011-08-31 Impact factor: 3.157
Authors: Russ S Kotwal; Laura L F Scott; Jud C Janak; Bruce W Tarpey; Jeffrey T Howard; Edward L Mazuchowski; Frank K Butler; Stacy A Shackelford; Jennifer M Gurney; Zsolt T Stockinger Journal: J Trauma Acute Care Surg Date: 2018-07 Impact factor: 3.313
Authors: John B Holcomb; Michael D Swartz; Stacia M DeSantis; Thomas J Greene; Erin E Fox; Deborah M Stein; Eileen M Bulger; Jeffrey D Kerby; Michael Goodman; Martin A Schreiber; Martin D Zielinski; Terence O'Keeffe; Kenji Inaba; Jeffrey S Tomasek; Jeanette M Podbielski; Savitri N Appana; Misung Yi; Charles E Wade Journal: J Trauma Acute Care Surg Date: 2017-07 Impact factor: 3.313
Authors: Thomas Thiele; Gregor Hron; Sarah Kellner; Christina Wasner; Antje Westphal; Theodore E Warkentin; Andreas Greinacher; Kathleen Selleng Journal: Blood Transfus Date: 2015-07-09 Impact factor: 3.443
Authors: Hunter B Moore; Ernest E Moore; Michael P Chapman; Kevin McVaney; Gary Bryskiewicz; Robert Blechar; Theresa Chin; Clay Cothren Burlew; Fredric Pieracci; F Bernadette West; Courtney D Fleming; Arsen Ghasabyan; James Chandler; Christopher C Silliman; Anirban Banerjee; Angela Sauaia Journal: Lancet Date: 2018-07-20 Impact factor: 79.321
Authors: John B Holcomb; Daryn P Donathan; Bryan A Cotton; Deborah J Del Junco; Georgian Brown; Toni von Wenckstern; Jeanette M Podbielski; Elizabeth A Camp; Rhonda Hobbs; Yu Bai; Michelle Brito; Elizabeth Hartwell; James Red Duke; Charles E Wade Journal: Prehosp Emerg Care Date: 2014-06-16 Impact factor: 3.077
Authors: Nicholas Crombie; Heidi A Doughty; Jonathan R B Bishop; Amisha Desai; Emily F Dixon; James M Hancox; Mike J Herbert; Caroline Leech; Simon J Lewis; Mark R Nash; David N Naumann; Gemma Slinn; Hazel Smith; Iain M Smith; Rebekah K Wale; Alastair Wilson; Natalie Ives; Gavin D Perkins Journal: Lancet Haematol Date: 2022-03-07 Impact factor: 18.959